Sentence examples for increase discrepancy from inspiring English sources
"increase discrepancy" is a grammatically correct phrase and can be used in written English
It means to make the difference or discrepancy between two things larger. Example: The continuous increase in prices has led to a growing discrepancy between the rich and poor in our society.
During CRRT, nonetheless, many variables may affect the effective delivery of treatment dose: if the molecular weight of different solutes is certainly an important aspect, the time factor appears to be an essential variable as well; interruptions cause a clinically significant therapy downtime and increase discrepancy between prescription and effective delivery [ 8].
The same analysis depending on the type of cancer risk (breast/ovarian or colon) did not increase discrepancies.
To what extent a complete disclosure statement, including not only all potential or actual conflicts of interest but also detailed information on individual contributions to the study and publication, will increase discrepancies between guidelines and practice remains to be seen.
Results indicated that only the personalized normative feedback increased discrepancy and intention to reduce alcohol use.
However, the predictions of USC Mech and Li Mech with prompt reactions show increased discrepancy between experiments and predictions.
Comparison of the theoretical values with the experimentally attained moduli showed an increasing discrepancy for higher molecular rigidity.
Investors have been troubled by the potential of an increased discrepancy between Moody's and Standard & Poor's assessment of Japan's ability to handle its mounting debt, which currently stands at 100percentt of its gross domestic product.
The researchers claim that the increasing discrepancy between THC and CBD levels in cannabis could increase the number of users at risk of developing psychotic disorders – a view supported by a number of academics not involved in the research.
The Process Analytical Technology PATT) initiative of the FDA is a reaction on the increasing discrepancy between current possibilities in process supervision and control of pharmaceutical production processes and its current application in industrial manufacturing processes.
Because of an increasing discrepancy between the number of potential liver graft recipients and the number of organs available, scientists are trying to create artificial liver to mimic normal liver function and therefore, to support the patient's liver when in dysfunction.
The increasing discrepancy in more recent years is mainly due to few countries (mainly Poland and France), which will deserve further investigation, e.g. inappropriate data or assumption used by the CBM model or problems with the GHGIs.
